As the world is recognising the World Intellectual Property Day on April 26, the group ReAct considers how the current system uses Intellectual Property and licenses in the case of antibiotics. In this interview, our head of policy Esteban Burrone and ReAct examine the particular role that the Medicines Patent Pool and licensing could play in such an end-to-end model.